Blackstone Bets On Pharma In First Japan Buy, But Why?

Major private equity group Blackstone buys into pharma for its first acquisition in Japan, but amid challenges in the sector, the attractions take some unraveling.

Business teamwork puzzle pieces.
Blackstone Makes First Japan Acquisition • Source: Shutterstsock

Funds under The Blackstone Group are buying the private specialty firm Ayumi Pharmaceutical, in a signal that the US private equity giant sees attractive returns down the road from what is its first controlling private investment in Japan.

The transaction, expected to close in the calendar second quarter for a reported (but unconfirmed) sum of around JPY100bn ($910m)...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia